4-(4-Bromobenzyl)piperidin-4-ol, 98%, 250mg

(4S,4'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-tert-butyloxazole], 97%, 100mg

5-Bromobenzo[d]oxazole-2-carbonitrile, 98%, 100mg

ETHYL MALONYL HYDRAZIDE, 97.0%, 5g

2-Ethylhexyl 4,6-Dibromo-3-fluorothieno[3,4-b]thiophene-2-carboxylate>97.0%(GC)100mg

TRIPTYCENE, 98.0%, 1g

Stagno ICP soluzione standard, ROTI®Star, 1000 mg/l Sn, densità (D) 1,05 g/cm³

Nonaethylene Glycol Monomethyl Ether>90.0%(GC)1g

ETHYL 7-AMINOQUINOLINE-2-CARBOXYLATE, 95.0%, 250mg

4,4''-DIBROMO-3',4',5',6'-TETRAKIS(4-BROMOPHENYL)-1,1':2',1''-TERPHENYL, 95%, 10g

4-Chloro-1H-pyrazol-3-ylamine, 95.0%, 100mg

4-Bromo-3-chloro-2-fluorophenyl isothiocyanate, 97.0%, 1g